INPP5F expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.00659505572776E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.69879690712105E-11 |
Normal-vs-Stage2 |
9.90999999950226E-07 |
Normal-vs-Stage3 |
7.25890458852518E-11 |
Normal-vs-Stage4 |
1.272480E-02 |
Stage1-vs-Stage2 |
9.463600E-01 |
Stage1-vs-Stage3 |
4.274000E-01 |
Stage1-vs-Stage4 |
7.106400E-01 |
Stage2-vs-Stage3 |
5.345000E-01 |
Stage2-vs-Stage4 |
7.677000E-01 |
Stage3-vs-Stage4 |
5.224200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.60039759222741E-11 |
Normal-vs-AfricanAmerican |
8.04909999763126E-08 |
Normal-vs-Asian |
4.332800E-01 |
Caucasian-vs-AfricanAmerican |
4.279800E-01 |
Caucasian-vs-Asian |
5.279800E-01 |
AfricanAmerican-vs-Asian |
6.200200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62458935193399E-12 |
Normal-vs-Female |
2.386100E-04 |
Male-vs-Female |
1.096200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.06999994922796E-09 |
Normal-vs-Extreme_Weight |
1.04550035295858E-10 |
Normal-vs-Obese |
1.22790000389728E-08 |
Normal-vs-Extreme_Obese |
1.73020000548973E-08 |
Normal_Weight-vs-Extreme_Weight |
8.103800E-01 |
Normal_Weight-vs-Obese |
4.718200E-01 |
Normal_Weight-vs-Extreme_Obese |
1.588430E-01 |
Extreme_Weight-vs-Obese |
6.073400E-01 |
Extreme_Weight-vs-Extreme_Obese |
1.579160E-01 |
Obese-vs-Extreme_Obese |
6.922200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.872500E-02 |
Normal-vs-Age(41-60Yrs) |
3.78459996674962E-09 |
Normal-vs-Age(61-80Yrs) |
2.17714735128993E-13 |
Normal-vs-Age(81-100Yrs) |
5.26230000019723E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.133420E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.183300E-03 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.348000E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.410400E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.753230E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.706200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.69700031804609E-10 |
Normal-VS-Type2 PRCC |
5.80091530366644E-13 |
Normal-VS-KIRP CIMP |
5.098900E-03 |
Normal-VS-Unclassified PRCC |
8.407900E-04 |
Type1 PRCC-VS-Type2 PRCC |
4.695800E-02 |
Type1 PRCC-VS-KIRP CIMP |
1.774380E-02 |
Type1 PRCC-VS-Unclassified PRCC |
3.989800E-01 |
Type2 PRCC-VS-KIRP CIMP |
1.104280E-02 |
Type2 PRCC-VS-Unclassified PRCC |
7.418100E-02 |
KIRP CIMP-VS-Unclassified PRCC |
3.826200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
9.79216707719388E-14 |
Normal-vs-N1 |
1.25279999996231E-06 |
Normal-vs-N2 |
1.115810E-03 |
N0-vs-N1 |
7.145800E-02 |
N0-vs-N2 |
9.218200E-01 |
N1-vs-N2 |
4.964000E-01 |
|
|